The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Turkel Catherine C. since 2017.
This trader's CIK number is 1705278.
At the time of last reporting, Turkel Catherine C. was the Director of Lexaria Bioscience Corp.. (stock ticker symbol LEXX).
Also see all insider trading activities at Lexaria Bioscience Corp..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | NVUS | 0 | $0 | 9,537 | $18,613 | 0 | $0 |
| 2018 | NVUS | 34,485 | $164,338 | 0 | $0 | 0 | $0 |
| 2017 | NVUS | 11,111 | $110,998 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | LEXX | 1,600 | $5,008 | 0 | $0 | 0 | $0 |
| 2023 | LEXX | 1,500 | $4,267 | 0 | $0 | 0 | $0 |
1. Eledon Pharmaceuticals, Inc. (NVUS)
2. Lexaria Bioscience Corp. (LEXX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-21 | NVUS | Sale | 1,914 | 1.91 | 3,657 |
| 2019-05-20 | NVUS | Sale | 7,623 | 1.96 | 14,956 |
| 2018-09-12 | NVUS | Buy | 16,632 | 5.02 | 83,476 |
| 2018-09-11 | NVUS | Buy | 17,048 | 4.56 | 77,670 |
| 2018-09-05 | NVUS | Buy | 805 | 3.97 | 3,192 |
| 2017-05-10 | NVUS | Buy | 11,111 | 9.99 | 110,998 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-12 | LEXX | Buy | 1,600 | 3.13 | 5,008 |
| 2023-02-09 | LEXX | Buy | 1,500 | 2.85 | 4,267 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turkel Catherine C. (Director of Lexaria Bioscience Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.